ARTICLE | Company News
Ferring sales and marketing update
March 9, 2015 7:00 AM UTC
Ferring launched Cortiment MMX budesonide in Europe to treat adults with active mild to moderate ulcerative colitis in cases where mesalazine has not been sufficient. The approved dose is a 9 mg tabl...